10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __ to __

Commission File Number: 001-37961

_________________________________________________________________________________________________________________________

ICHOR HOLDINGS, LTD.

(Exact Name of Registrant as Specified in its Charter)

_________________________________________________________________________________________________________________________

Cayman Islands	Not Applicable
( State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3185 Laurelview Ct. Fremont, CA	94538
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (510) 897-5200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Ordinary Shares, par value $0.0001	ICHR	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x     No  o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S‑T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x     No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non‑accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b‑2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	o
Non‑accelerated filer	o	Small reporting company	o
Emerging Growth Company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b‑2 of the Exchange Act). Yes  o     No  x

As of May 5, 2023, the registrant had 29,055,904 ordinary shares, $0.0001 par value per share, outstanding.

TABLE OF CONTENTS

PART I
ITEM 1.	FINANCIAL STATEMENTS (UNAUDITED)	1
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	13
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	22
ITEM 4.	CONTROLS AND PROCEDURES	22
PART II
ITEM 1.	LEGAL PROCEEDINGS	24
ITEM 1A.	RISK FACTORS	24
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	24
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	24
ITEM 4.	MINE SAFETY DISCLOSURES	24
ITEM 5.	OTHER INFORMATION	24
ITEM 6.	EXHIBITS	24
SIGNATURES		25

PART I

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

ICHOR HOLDINGS, LTD.

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

(unaudited)

	March 31, 2023		December 30, 2022
Assets
Current assets:
Cash and cash equivalents	$	68,837	$	86,470
Accounts receivable, net	122,693		136,321
Inventories	271,538		283,660
Prepaid expenses and other current assets	6,530		7,007
Total current assets	469,598		513,458
Property and equipment, net	101,481		98,055
Operating lease right-of-use assets	40,609		40,557
Other noncurrent assets	12,660		12,926
Deferred tax assets, net	12,345		11,322
Intangible assets, net	68,056		72,022
Goodwill	335,402		335,402
Total assets	$	1,040,151	$	1,083,742
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable	$	68,030	$	110,165
Accrued liabilities	21,417		23,616
Other current liabilities	11,821		15,815
Current portion of long-term debt	7,500		7,500
Current portion of lease liabilities	9,457		9,196
Total current liabilities	118,225		166,292
Long-term debt, less current portion, net	291,459		293,218
Lease liabilities, less current portion	31,988		31,828
Deferred tax liabilities, net	29		29
Other non-current liabilities	4,986		4,879
Total liabilities	446,687		496,246
Shareholders’ equity:
Preferred shares ($0.0001 par value; 20,000,000 shares authorized; 0 shares issued and outstanding)	—		—
Ordinary shares ($0.0001 par value; 200,000,000 shares authorized; 29,034,946 and 28,861,949 shares outstanding, respectively; 33,472,385 and 33,299,388 shares issued, respectively)	3		3
Additional paid in capital	437,388		431,415
Treasury shares at cost (4,437,439 shares)	(91,578)		(91,578)
Retained earnings	247,651		247,656
Total shareholders’ equity	593,464		587,496
Total liabilities and shareholders’ equity	$	1,040,151	$	1,083,742

The accompanying notes are an integral part of these consolidated financial statements.

1

ICHOR HOLDINGS, LTD.

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

(unaudited)

	Three Months Ended
	March 31, 2023		April 1, 2022
Net sales	$	225,870	$	293,146
Cost of sales	192,630		249,214
Gross profit	33,240		43,932
Operating expenses:
Research and development	4,313		4,851
Selling, general, and administrative	20,167		23,267
Amortization of intangible assets	3,966		5,349
Total operating expenses	28,446		33,467
Operating income	4,794		10,465
Interest expense, net	4,550		1,532
Other expense, net	784		84
Income (loss) before income taxes	(540)		8,849
Income tax expense (benefit)	(535)		810
Net income (loss)	$	(5)	$	8,039
Net income (loss) per share
Basic	$	0.00	$	0.28
Diluted	$	0.00	$	0.28
Shares used to compute Net income (loss) per share:
Basic	28,984,878		28,592,629
Diluted	28,984,878		29,023,455

The accompanying notes are an integral part of these consolidated financial statements.

2

ICHOR HOLDINGS, LTD.

Consolidated Statements of Shareholders’ Equity

(in thousands, except share amounts)

(unaudited)

For the three months ending March 31, 2023	Ordinary Shares			Additional Paid-In Capital		Treasury Shares			Retained Earnings		Total Shareholders' Equity
	Shares	Amount				Shares	Amount
Balance at December 30, 2022	28,861,949	$	3	$	431,415	4,437,439	$	(91,578)	$	247,656	$	587,496
Ordinary shares issued from exercise of stock options	92,766	—		2,126		—	—		—		2,126
Ordinary shares issued from vesting of restricted share units	32,527	—		(692)		—	—		—		(692)
Ordinary shares issued from employee share purchase plan	47,704	—		902		—	—		—		902
Share-based compensation expense	—	—		3,637		—	—		—		3,637
Net loss	—	—		—		—	—		(5)		(5)
Balance at March 31, 2023	29,034,946	$	3	$	437,388	4,437,439	$	(91,578)	$	247,651	$	593,464

For the three months ending April 1, 2022	Ordinary Shares			Additional Paid-In Capital		Treasury Shares			Retained Earnings		Total Shareholders' Equity
	Shares	Amount				Shares	Amount
Balance at December 31, 2021	28,551,160	$	3	$	417,438	4,437,439	$	(91,578)	$	174,852	$	500,715
Ordinary shares issued from exercise of stock options	42,753	—		955		—	—		—		955
Ordinary shares issued from vesting of restricted share units	34,994	—		(777)		—	—		—		(777)
Share-based compensation expense	—	—		2,897		—	—		—		2,897
Net income	—	—		—		—	—		8,039		8,039
Balance at April 1, 2022	28,628,907	$	3	$	420,513	4,437,439	$	(91,578)	$	182,891	$	511,829

The accompanying notes are an integral part of these consolidated financial statements.

3

ICHOR HOLDINGS, LTD.

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

	Three Months Ended
	March 31, 2023		April 1, 2022
Cash flows from operating activities:
Net income (loss)	$	(5)	$	8,039
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	8,489		9,315
Share-based compensation	3,637		2,897
Deferred income taxes	(1,023)		(37)
Amortization of debt issuance costs	116		117
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net	13,628		(10,544)
Inventories	12,122		(27,718)
Prepaid expenses and other assets	2,705		(650)
Accounts payable	(43,018)		(18,209)
Accrued liabilities	(1,797)		2,182
Other liabilities	(5,727)		(1,670)
Net cash used in operating activities	(10,873)		(36,278)
Cash flows from investing activities:
Capital expenditures	(6,819)		(3,417)
Net cash used in investing activities	(6,819)		(3,417)
Cash flows from financing activities:
Issuance of ordinary shares under share-based compensation plans	2,626		1,368
Employees' taxes paid upon vesting of restricted share units	(692)		(777)
Repayments on term loan	(1,875)		(1,875)
Net cash provided by (used in) financing activities	59		(1,284)
Net decrease in cash	(17,633)		(40,979)
Cash at beginning of period	86,470		75,495
Cash at end of period	$	68,837	$	34,516
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	$	4,745	$	1,395
Cash paid during the period for taxes, net of refunds	$	104	$	106
Supplemental disclosures of non-cash activities:
Capital expenditures included in accounts payable	$	2,426	$	2,278
Right-of-use assets obtained in exchange for new operating lease liabilities, including those acquired through acquisitions	$	2,261	$	6,067

The accompanying notes are an integral part of these consolidated financial statements.

4

ICHOR HOLDINGS, LTD.

Notes to Consolidated Financial Statements

(dollar figures in tables in thousands, except per share amounts)

(unaudited)

Note 1 – Basis of Presentation and Selected Significant Accounting Policies

Basis of Presentation

These consolidated unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”). All intercompany balances and transactions have been eliminated upon consolidation. All dollar figures presented in tables in the notes to consolidated financial statements are in thousands, except per share amounts. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10‑K for the year ended December 30, 2022.

Year End

We use a 52- or 53-week fiscal year ending on the last Friday in December. Our fiscal years ending December 29, 2023 and December 30, 2022 each are 52 weeks. References to 2023 and 2022 relate to the fiscal years then ended. The three-month periods ended March 31, 2023 and April 1, 2022 each are 13 weeks. References to the first quarter of 2023 and 2022 relate to the three-month periods then ended.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods presented. We base our estimates and judgments on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results could differ from the estimates made by management. Significant estimates include inventory valuation and impairment analysis for both definite‑lived intangible assets and goodwill.

Cash and Cash Equivalents

Cash and cash equivalents consist of deposits and financial instruments which are readily convertible into cash and have original maturities of 90 days or less at the time of acquisition.

Fair Value of Financial Instruments

The carrying values of our financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued liabilities, and long-term debt, net of unamortized debt issuance costs, approximate fair value.

5

Revenue Recognition

We recognize revenue when control of promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. This amount is recorded as net sales in our consolidated statements of operations.

Transaction price – In most of our contracts, prices are generally determined by a customer-issued purchase order and generally remain fixed over the duration of the contract. Certain contracts contain variable consideration, including early-payment discounts and rebates. When a contract includes variable consideration, we evaluate the estimate of the variable consideration to determine whether the estimate needs to be constrained; therefore, we include the variable consideration in the transaction price only to the extent that it is probable that a significant reversal will not occur. Variable consideration estimates are updated at each reporting date. Historically, we have not incurred significant costs to obtain a contract. All amounts billed to a customer relating to shipping and handling are classified as net sales, while all costs incurred by us for shipping and handling are classified as cost of sales.

Performance obligations – Substantially all of our performance obligations pertain to promised goods (“products”), which are primarily comprised of fluid delivery subsystems, weldments, and other components. Most of our contracts contain a single performance obligation and are generally completed within twelve months. Product sales are recognized at a point-in-time, generally upon delivery, as such term is defined within the contract, as that is when control of the promised good has transferred. Products are covered by a standard assurance warranty, generally extended for a period of one to two years depending on the customer, which promises that delivered products conform to contract specifications. As such, we account for such warranties under ASC 460, Guarantees, and not as a separate performance obligation.

Contract balances – Accounts receivable represents our unconditional right to receive consideration from our customers. Accounts receivable are carried at invoice price less an estimate for doubtful accounts and estimated payment discounts. Payment terms vary by customer but are generally due within 15-60 days. Historically, we have not incurred significant payment issues with our customers. We had no significant contract assets or liabilities on our consolidated balance sheets in any of the periods presented.

Accounting Pronouncements Recently Adopted

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021‑08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. We adopted the ASU on the first day of 2023 and it did not have a material impact on our consolidated financial statements.

Note 2 – Inventories

Inventories consist of the following:

	March 31, 2023		December 30, 2022
Raw materials	$	196,504	$	197,726
Work in process	39,733		56,291
Finished goods	54,306		47,186
Excess and obsolete adjustment	(19,005)		(17,543)
Total inventories	$	271,538	$	283,660

6

Note 3 – Property and Equipment and Other Noncurrent Assets

Property and equipment consist of the following:

	March 31, 2023		December 30, 2022
Machinery	$	96,338	$	90,507
Leasehold improvements	43,556		43,129
Computer software, hardware, and equipment	10,053		9,664
Office furniture, fixtures, and equipment	1,354		1,337
Vehicles	401		401
Construction-in-process	21,510		19,869
	173,212		164,907
Less accumulated depreciation	(71,731)		(66,852)
Total property and equipment, net	$	101,481	$	98,055

Depreciation expense was $4.3 million and $4.0 million for the first quarter of 2023 and 2022, respectively.

Cloud Computing Implementation Costs

We capitalize implementation costs associated with hosting arrangement that are service contracts. These costs are recorded to prepaid expenses or other noncurrent assets. To-date, these costs are those incurred to implement a new company-wide ERP system. The balance of capitalized cloud computing implementation costs, net of accumulated amortization, was $11.4 million and $11.6 million as of March 31, 2023 and December 30, 2022, respectively, and is included in other assets on our consolidated balance sheets. The related amortization expense was $0.2 million and $0.2 million during the first quarter of 2023 and 2022, respectively, and is included in selling, general, and administrative expense on our consolidated statements of operations.

Note 4 – Intangible Assets

Definite‑lived intangible assets consist of the following:

	March 31, 2023
	Gross value		Accumulated amortization		Accumulated impairment charges		Carrying amount		Weighted average useful life
Customer relationships	117,022		(55,202)		—		61,820		8.4 years
Developed technology	11,047		(4,811)		—		6,236		10.0 years
Total intangible assets	$	128,069	$	(60,013)	$	—	$	68,056

	December 30, 2022
	Gross value		Accumulated amortization		Accumulated impairment charges		Carrying amount		Weighted average useful life
Customer relationships	117,022		(51,337)		—		65,685		8.4 years
Developed technology	11,047		(4,710)		—		6,337		10.0 years
Total intangible assets	$	128,069	$	(56,047)	$	—	$	72,022

7

Note 5 – Leases

Operating lease right-of-use (“ROU”) assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating operating lease ROU assets and operating lease liabilities, we use the non-cancelable lease term plus options to extend that we are reasonably certain to take. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. Our leases generally do not provide an implicit rate. As such, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

We lease facilities under various non-cancelable operating leases expiring through 2031. In addition to base rental payments, we are generally responsible for our proportionate share of operating expenses, including facility maintenance, insurance, and property taxes. As these amounts are variable, they are not included in lease liabilities.

The components of lease expense are as follows:

	Three Months Ended
	March 31, 2023		April 1, 2022
Operating lease cost	$	2,411	$	2,045

Supplemental cash flow information related to leases is as follows:

	Three Months Ended
	March 31, 2023		April 1, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,237	$	1,823

Supplemental balance sheet information related to leases is as follows:

	March 31, 2023	December 30, 2022
Weighted-average remaining lease term of operating leases	5.2 years	5.3 years
Weighted-average discount rate of operating leases	3.2%	3.0%

Future minimum lease payments under non-cancelable leases are as follows as of March 31, 2023:

2023, remaining	$	7,117
2024	9,074
2025	8,418
2026	7,968
2027	6,968
Thereafter	5,367
Total future minimum lease payments	44,912
Less imputed interest	(3,467)
Total lease liabilities	$	41,445

8

Note 6 – Income Taxes

Income tax information for the periods reported is as follows:

	Three Months Ended
	March 31, 2023			April 1, 2022
Income tax expense (benefit)	$	(535)		$	810
Income (loss) before income taxes	$	(540)		$	8,849
Effective income tax rate	99.1		%	9.2		%

Our effective tax rates for the three months ended March 31, 2023 and April 1, 2022 differ from the statutory rate primarily due to taxes on foreign income that differ from the U.S. tax rate, including a tax holiday in Singapore. Our effective tax rate of 99.1% for the first quarter of 2023 is primarily due to projected pre-tax loss in the U.S. for 2023, which generates tax benefits, partially offset by projected pre-tax income in Singapore, our primary source of non-U.S. pre-tax income and for which we participate in a tax holiday through 2026.

The ending balance for the unrecognized tax benefits for uncertain tax positions was approximately $4.5 million at March 31, 2023. The related interest and penalties were insignificant. The uncertain tax positions that are reasonably possible to decrease in the next twelve months are insignificant.

As of March 31, 2023, we were under examination by the Inland Revenue Board of Malaysia for the years 2016 to 2020.

Note 7 – Employee Benefit Programs

401(k) Plan

We sponsor a 401(k) plan available to employees of our U.S.‑based subsidiaries. Participants may make salary deferral contributions not to exceed 50% of a participant’s annual compensation or the maximum amount otherwise allowed by law. Eligible employees receive a discretionary matching contribution equal to 50% of a participant’s deferral, up to an annual matching maximum of 4% of a participant’s annual compensation. Matching contributions were $0.9 million and $1.0 million for the first quarter of 2023 and 2022, respectively.

Note 8 – Long-Term Debt

Long‑term debt consists of the following:

	March 31, 2023		December 30, 2022
Term loan	$	140,625	$	142,500
Revolving credit facility	160,000		160,000
Total principal amount of long-term debt	300,625		302,500
Less unamortized debt issuance costs	(1,666)		(1,782)
Total long-term debt, net	298,959		300,718
Less current portion	(7,500)		(7,500)
Total long-term debt, less current portion, net	$	291,459	$	293,218

On October 29, 2021, we entered into an amended and restated credit agreement, which includes a group of financial institutions as direct lenders underlying the agreement. The credit agreement includes a $150.0 million term loan facility and a $250.0 million revolving credit facility (together, “credit facilities”). Term loan principal payments of $1.9 million are due on a quarterly basis. The credit facilities mature on October 29, 2026.

9

Interest is charged at either the Base Rate or the Bloomberg Short-Term Bank Yield (“BSBY”) Rate (as such terms are defined in the credit agreement) at our option, plus an applicable margin. The Base Rate is equal to the higher of i) the Prime Rate, ii) the Federal Funds Rate plus 0.5%, or iii) the BSBY Rate plus 1.00%. The applicable margin on Base Rate and BSBY Rate loans is 0.375-1.375% and 1.375-2.375% per annum, respectively, depending on our leverage ratio, which is based on trailing 12-month EBITDA, as defined in our credit agreement. We are also charged a commitment fee of 0.175%-0.350%, depending on our leverage ratio, on the unused portion of our revolving credit facility. Base Rate interest payments and commitment fees are due quarterly. BSBY Rate interest payments are due on the last day of the applicable interest period, or quarterly for applicable interest periods longer than 3 months. At March 31, 2023, our credit facilities bore interest under the BSBY rate option of 6.51%.

Note 9 – Share‑Based Compensation

The 2016 Omnibus Incentive Plan (the “2016 Plan”) provides for grants of share‑based awards to employees, directors, and consultants. Awards may be in the form of stock options (“options”), tandem and non‑tandem stock appreciation rights, restricted share awards or restricted share units (“RSUs”), performance awards, and other share‑based awards. Forfeited or expired awards are returned to the incentive plan pool for future grants. Awards generally vest over four years, 25% on the first anniversary of the date of grant and quarterly thereafter over the remaining 3 years. Upon vesting of RSUs, shares are withheld to cover statutory minimum withholding taxes. Shares withheld are not reflected as an issuance of ordinary shares within our consolidated statements of shareholders’ equity, as the shares were never issued, and the associated tax payments are reflected as financing activities within our consolidated statements of cash flows.

Share‑based compensation expense across all plans for options, RSUs, and employee share purchase rights was $3.6 million and $2.9 million for the first quarter of 2023 and 2022.

Stock Options

The following table summarizes option activity:

	Number of Stock Options
	Service condition	Weighted average exercise price per share		Weighted average remaining contractual term	Aggregate intrinsic value
Outstanding, December 30, 2022	805,115	$	23.35
Granted	—	$	0.00
Exercised	(92,766)	$	22.91
Forfeited or expired	(1,444)	$	22.18
Outstanding, March 31, 2023	710,905	$	23.41	2.6 years	$	6,634
Exercisable, March 31, 2023	634,134	$	23.36	2.4 years	$	5,951

Restricted Share Units

The following table summarizes RSU activity:

	Number of Restricted Share Units
	Service condition	Performance condition	Market condition	Weighted average grant-date fair value per share
Unvested, December 30, 2022	860,595	57,562	86,342	$	30.26
Granted	69,675	—	—	$	27.04
Vested	(51,938)	—	—	$	33.57
Forfeited	(11,936)	—	—	$	31.81
Unvested, March 31, 2023	866,396	57,562	86,342	$	29.78

10

Employee Share Purchase Plan

The 2017 Employee Stock Purchase Plan (the “2017 ESPP”) grants employees the ability to designate a portion of their base-pay to purchase ordinary shares at a price equal to 85% of the fair market value of our ordinary shares on the first or last day of each 6 month purchase period. Purchase periods begin on January 1 or July 1 and end on June 30 or December 31, or the next business day if such date is not a business day. Shares are purchased on the last day of the purchase period.

As of March 31, 2023, approximately 2.2 million ordinary shares remain available for purchase under the 2017 ESPP.

Note 10 – Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share and a reconciliation of the numerator and denominator used in the calculation:

	Three Months Ended
	March 31, 2023		April 1, 2022
Numerator:
Net income (loss)	$	(5)	$	8,039
Denominator:
Basic weighted average ordinary shares outstanding	28,984,878		28,592,629
Dilutive effect of options	—		292,828
Dilutive effect of RSUs	—		135,860
Dilutive effect of ESPP	—		2,138
Diluted weighted average ordinary shares outstanding	28,984,878		29,023,455
Securities excluded from the calculation of diluted weighted average ordinary shares outstanding (1)	1,879,000		267,000
Net income (loss) per share:
Basic	$	0.00	$	0.28
Diluted	$	0.00	$	0.28

(1)Represents potentially dilutive options and RSUs excluded from the calculation of diluted weighted average ordinary shares outstanding, because including them would have been antidilutive under the treasury stock method.

Note 11 – Segment Information

Our Chief Operating Decision Maker, the Chief Executive Officer, reviews our results of operations on a consolidated level and executive staff is structured by function rather than by product category. Additionally, key resources, decisions, and assessment of performance are analyzed at a company‑wide level. Therefore, we operate in one operating segment.

Foreign operations are conducted primarily through our wholly owned subsidiaries in Singapore and Malaysia, and to a lesser degree, Scotland, Korea, and Mexico. Our principal markets include North America, Asia, and to a lesser degree, Europe.

11

Sales by geographic area represents sales to unaffiliated customers based upon the location to which the products were shipped. The following table sets forth sales by geographic area:

	Three Months Ended
	March 31, 2023		April 1, 2022
United States of America	$	89,052	$	142,470
Singapore	82,286		103,295
Europe	29,986		24,392
Other	24,546		22,989
Total net sales	$	225,870	$	293,146

Foreign long-lived assets, exclusive of deferred tax assets, were $52.5 million and $52.8 million at March 31, 2023 and December 30, 2022, respectively.

12

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Statement Concerning Forward-Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. You should not place undue reliance on these statements. All statements other than statements of historical fact included in this report are forward-looking statements. These statements relate to analyses and other information, which are based on forecasts of future results and estimates of amounts not yet determinable. These statements also relate to our future prospects, developments and business strategies. These forward-looking statements are identified by the use of terms and phrases such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will” and similar terms and phrases, including references to assumptions. However, these words are not the exclusive means of identifying such statements. These statements are contained in many sections of this report, including those in Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Although we believe that our plans, intentions and expectations reflected in or suggested by such forward-looking statements are reasonable, we cannot assure you that we will achieve those plans, intentions or expectations. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected. Important factors that could cause actual results to differ materially from our expectations, or cautionary statements, include economic downturns and market conditions beyond our control, including periods of inflation, slower growth or recession, changes to fiscal and monetary policy, higher interest rates, currency fluctuations, challenges in the supply chain, export restrictions, and any disruptions in European economies as a result of the conflict in Ukraine; the quality of global financial markets; our dependence on expenditures by manufacturers in the semiconductor capital equipment industry; our reliance on a very small number of original equipment manufacturer customers for a significant portion of our sales; our customers’ significant negotiating leverage; competition in our industry; and other factors set forth in this report, and those set forth in Part I – Item 1A. Risk Factors of our 2022 Annual Report on Form 10‑K and our other filings with the Securities and Exchange Commission (“SEC”). All written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements contained in Part I – Item 1A. Risk Factors to our 2022 Annual Report on Form 10-K, as well as other cautionary statements that are made from time to time in our other filings with the SEC and public communications. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.

We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated unaudited financial statements and related notes included elsewhere in this report.

Overview

We are a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. Our product offerings include gas and chemical delivery systems and subsystems, collectively known as fluid delivery systems and subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. Our gas delivery subsystems deliver, monitor, and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition. Our chemical delivery systems and subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as chemical-mechanical planarization, electroplating, and cleaning. We also provide precision-machined components, weldments, e‑beam and laser-welded components, precision vacuum and hydrogen brazing and surface treatment technologies, and other proprietary products. This vertically integrated portion of our business is primarily focused on metal and plastic parts that are used in gas and chemical systems, respectively.

13

Fluid delivery subsystems ensure accurate measurement and uniform delivery of specialty gases and chemicals at critical steps in the semiconductor manufacturing processes. Any malfunction or material degradation in fluid delivery reduces yields and increases the likelihood of manufacturing defects in these processes. Most OEMs outsource all or a portion of the design, engineering, and manufacturing of their gas delivery subsystems to a few specialized suppliers, including us. Additionally, many OEMs are outsourcing the design, engineering, and manufacturing of their chemical delivery subsystems due to the increased fluid expertise required to manufacture these subsystems. Outsourcing these subsystems has allowed OEMs to leverage the suppliers’ highly specialized engineering, design, and production skills while focusing their internal resources on their own value-added processes. We believe that this outsourcing trend has enabled OEMs to reduce their costs and development time, as well as provide growth opportunities for specialized subsystems suppliers like us.

We have a global footprint with production facilities in California, Minnesota, Oregon, Texas, Singapore, Malaysia, the United Kingdom, Korea, and Mexico.

The following table summarizes key financial information for the periods indicated. Amounts are presented in accordance with GAAP unless explicitly identified as being a non-GAAP metric. For a description of our non-GAAP metrics and reconciliations to the most comparable GAAP metrics, please refer below to the section entitled Non-GAAP Financial Results within this report.

	Three Months Ended
	March 31, 2023			April 1, 2022
	(dollars in thousands, except per share amounts)
Net sales	$	225,870		$	293,146
Gross margin	14.7		%	15.0		%
Non-GAAP gross margin	15.5		%	16.0		%
Operating margin	2.1		%	3.6		%
Non-GAAP operating margin	6.1		%	8.4		%
Net income (loss)	$	(5)		$	8,039
Non-GAAP net income	$	11,128		$	20,178
Diluted EPS	$	0.00		$	0.28
Non-GAAP diluted EPS	$	0.38		$	0.70

Macroeconomic Conditions and Business Update

In the first quarter of 2023, customer demand weakened due to overall reductions in spending for semiconductor capital equipment, the primary industry in which we operate. Many macroeconomic factors may have contributed to this reduced spending environment, including persistent levels of high inflation, higher interest rates, foreign currency rate fluctuations, supply chain disruptions, and reduced consumer confidence. Additionally, increased export controls for semiconductor-related goods and services shipped to China and delayed business investment in electronic memory capacity had varying levels of unfavorable consequences to our business.

To help mitigate these impacts and to better align our resources and cost structure with current and expected future levels of business, we initiated labor and other cost reduction initiatives starting in the fourth quarter of 2022 and continuing through the first quarter of 2023. As a result of these programs, we incurred severance charges of $1.1 million and $1.3 million in the fourth quarter of 2022 and first quarter of 2023, respectively. While challenging macroeconomic conditions have impacted our business and customers in the near-term, we believe demand for semiconductors, semiconductor equipment, and our products will return to growth and expect healthy long-term industry growth in the future.

Additionally, increased borrowing rates due to tightening monetary policy have increased our debt-service costs, as the interest on our outstanding indebtedness is variable (refer above to Part I – Item 1. Financial Statements (Unaudited) – Note 8—Long-Term Debt). An analysis of the changes in our debt-service cost is provided below under the heading Comparison of the three months ended March 31, 2023 and April 1, 2022 – Interest expense, net.

14

Results of Operations

The following table sets forth our unaudited results of operations for the periods presented. The period‑to‑period comparison of results is not necessarily indicative of results for future periods.

	Three Months Ended
	March 31, 2023		April 1, 2022
	(in thousands
Net sales	$	225,870	$	293,146
Cost of sales	192,630		249,214
Gross profit	33,240		43,932
Operating expenses:
Research and development	4,313		4,851
Selling, general, and administrative	20,167		23,267
Amortization of intangible assets	3,966		5,349
Total operating expenses	28,446		33,467
Operating income	4,794		10,465
Interest expense, net	4,550		1,532
Other expense, net	784		84
Income (loss) before income taxes	(540)		8,849
Income tax expense (benefit)	(535)		810
Net income (loss)	$	(5)	$	8,039

The following table sets forth our unaudited results of operations as a percentage of our total sales for the periods presented.

	Three Months Ended
	March 31, 2023	April 1, 2022
Net sales	100.0	100.0
Cost of sales	85.3	85.0
Gross profit	14.7	15.0
Operating expenses:
Research and development	1.9	1.7
Selling, general, and administrative	8.9	7.9
Amortization of intangible assets	1.8	1.8
Total operating expenses	12.6	11.4
Operating income	2.1	3.6
Interest expense, net	2.0	0.5
Other expense, net	0.3	0.0
Income (loss) before income taxes	(0.2)	3.0
Income tax expense (benefit)	(0.2)	0.3
Net income (loss)	—	2.7

15

Comparison of the three months ended March 31, 2023 and April 1, 2022

Net sales

	Three Months Ended				Change
	March 31, 2023		April 1, 2022		Amount		%
	(dollars in thousands)
Net sales	$	225,870	$	293,146	$	(67,276)	(22.9)	%

The decrease in net sales from the three months ended April 1, 2022 to the three months ended March 31, 2023 was primarily due to reduced customer demand stemming from reduced spending within the semiconductor capital equipment industry. Further detail is provided above under the section entitled Macroeconomic Conditions and Business Update.

Cost of sales, Gross profit, and Gross Margin

	Three Months Ended						Change
	March 31, 2023			April 1, 2022			Amount		%
	(dollars in thousands)
Cost of sales	$	192,630		$	249,214		$	(56,584)	(22.7)	%
Gross profit	$	33,240		$	43,932		$	(10,692)	(24.3)	%
Gross margin	14.7		%	15.0		%			-30	bps

The decrease in the gross amounts of cost of sales and gross profit from the three months ended April 1, 2022 to the three months ended March 31, 2023 was primarily due to the factors mentioned in the commentary above under the heading, “Net Sales.”

The decrease in gross margin from the three months ended April 1, 2022 to the three months ended March 31, 2023 was primarily due to reduced factory utilization as a result of lower volume due to reduced customer demand.

Research and development

	Three Months Ended				Change
	March 31, 2023		April 1, 2022		Amount		%
	(dollars in thousands)
Research and development	$	4,313	$	4,851	$	(538)	(11.1)	%

The decrease in research and development expenses from the three months ended April 1, 2022 to the three months ended March 31, 2023 was primarily due to reduced employee-related expense.

16

Selling, general, and administrative

	Three Months Ended				Change
	March 31, 2023		April 1, 2022		Amount		%
	(dollars in thousands)
Selling, general, and administrative	$	20,167	$	23,267	$	(3,100)	(13.3)	%

The decrease in selling, general, and administrative expense from the three months ended April 1, 2022 to the three months ended March 31, 2023 was primarily due to a $3.1 million loss accrual recorded in the first quarter of 2022 relating to an expected settlement of an employment-related legal matter and reduced employee-related expenses, inclusive of share-based compensation expense, of $0.5 million, partially offset by increased software and IT system costs of $0.5 million.

Amortization of intangible assets

	Three Months Ended				Change
	March 31, 2023		April 1, 2022		Amount		%
	(dollars in thousands)
Amortization of intangible assets	$	3,966	$	5,349	$	(1,383)	(25.9)	%

The decrease in amortization expense from the three months ended April 1, 2022 to the three months ended March 31, 2023 was primarily due to certain intangible assets becoming fully amortized in 2022.

Interest expense, net

	Three Months Ended						Change
	March 31, 2023			April 1, 2022			Amount		%
	(dollars in thousands)
Interest expense, net	$	4,550		$	1,532		$	3,018	197.0	%
Weighted average borrowings outstanding	$	302,479		$	294,959		$	7,520	2.5	%
Weighted average borrowing rate	6.10		%	1.83		%			+427 bps

The increase in interest expense, net from the three months ended April 1, 2022 to the three months ended March 31, 2023 was due to an increase in our average amount borrowed and an increase in our weighted average borrowing rate. The increase in the average amount borrowed was due to a net draw on our revolving credit facility of $15.0 million in the second quarter of 2022, partially offset by quarterly term loan payments. The increase in our weighted average borrowing rate is due to increased risk-free, short-term borrowing rates as a result of tightening monetary policy, which impacts BSBY, the variable component of our borrowing rate under our credit facilities.

17

Other expense, net

	Three Months Ended				Change
	March 31, 2023		April 1, 2022		Amount		%
	(dollars in thousands)
Other expense, net	$	784	$	84	$	700	833.3	%

The change in other expense, net from the three months ended April 1, 2022 to the three months ended March 31, 2023 was primarily due to currency exchange rate fluctuations during the quarter, reflecting a strengthening U.S. dollar against local currency payables of our foreign operations.

Income tax expense (benefit)

	Three Months Ended						Change
	March 31, 2023			April 1, 2022			Amount		%
	(dollars in thousands)
Income tax expense (benefit)	$	(535)		$	810		$	(1,345)	n/m
Income (loss) before income taxes	$	(540)		$	8,849		$	(9,389)	n/m
Effective income tax rate	99.1		%	9.2		%			+8,990 bps

The decrease in income tax expense from the three months ended April 1, 2022 to the three months ended March 31, 2023 was primarily due to decreased taxable income in the U.S.

Non‑GAAP Financial Results

Management uses certain non-GAAP metrics to evaluate our operating and financial results. We believe the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view our results from management’s perspective. Non-GAAP gross profit, operating income, and net income are defined as: gross profit, operating income, or net income (loss), respectively, excluding (1) amortization of intangible assets, share-based compensation expense, and discrete or infrequent charges and gains that are outside of normal business operations, including acquisition-related costs, contract and legal settlement gains and losses, facility shutdown costs, and severance costs associated with reduction-in-force programs, to the extent they are present in gross profit, operating income, and net income (loss), respectively; and (2) the tax impacts associated with these non-GAAP adjustments, as well as non-recurring discrete tax items. Non-GAAP diluted earnings per share ("EPS") is defined as non-GAAP net income divided by weighted average diluted ordinary shares outstanding during the period. Non-GAAP gross margin and non-GAAP operating margin are defined as non-GAAP gross profit and non-GAAP operating income, respectively, divided by net sales.

Non-GAAP results have limitations as an analytical tool, and you should not consider them in isolation or as a substitute for our results reported under GAAP. Other companies may calculate non-GAAP results differently or may use other measures to evaluate their performance, both of which could reduce the usefulness of our non-GAAP results as a tool for comparison.

Because of these limitations, you should consider non-GAAP results alongside other financial performance measures and results presented in accordance with GAAP. In addition, in evaluating non-GAAP results, you should be aware that in the future we will incur expenses such as those that are the subject of adjustments in deriving non-GAAP results and you should not infer from our presentation of non-GAAP results that our future results will not be affected by these expenses or other discrete or infrequent charges and gains that are outside of normal business operations.

18

The following table presents our unaudited non‑GAAP gross profit and non-GAAP gross margin and a reconciliation from gross profit, the most comparable GAAP measure, for the periods indicated:

	Three Months Ended
	March 31, 2023			April 1, 2022
	(dollars in thousands)
U.S. GAAP gross profit	$	33,240		$	43,932
Non-GAAP adjustments:
Share-based compensation	421			551
Fair value adjustment to inventory from acquisitions (1)	—			2,492
Other (2)	1,287			—
Non-GAAP gross profit	$	34,948		$	46,975
U.S. GAAP gross margin	14.7		%	15.0		%
Non-GAAP gross margin	15.5		%	16.0		%

(1)As part of the purchase price allocation of our acquisition of IMG Companies, LLC (“IMG”) in November 2021, we recorded acquired-inventories at fair value, resulting in a fair value step-up. This amount represents the release of the step-up to cost of sales as acquired-inventories were sold.

(2)Included in this amount are severance costs associated with our global reduction-in-force programs.

The following table presents our unaudited non‑GAAP operating income and non-GAAP operating margin and a reconciliation from operating income, the most comparable GAAP measure, for the periods indicated:

	Three Months Ended
	March 31, 2023			April 1, 2022
	(dollars in thousands, except per share amounts)
U.S. GAAP operating income	$	4,794		$	10,465
Non-GAAP adjustments:
Amortization of intangible assets	3,966			5,349
Share-based compensation	3,637			2,897
Settlement loss (1)	—			3,100
Fair value adjustment to inventory from acquisitions (2)	—			2,492
Acquisition costs (3)	—			275
Other (4)	1,324			—
Non-GAAP operating income	$	13,721		$	24,578
U.S. GAAP operating margin	2.1		%	3.6		%
Non-GAAP operating margin	6.1		%	8.4		%

(1)During the first quarter of 2022, we recorded a loss accrual of $3.1 million relating to an expected settlement of an employment-related legal matter. We expect the settlement to be finalized and paid in 2023.

(2)As part of the purchase price allocation of our acquisition of IMG, we recorded acquired-inventories at fair value, resulting in a fair value step-up. This amount represents the release of the step-up to cost of sales as acquired-inventories were sold.

(3)Included in this amount are transaction-related costs incurred in connection with our acquisition of IMG.

(4)Included in this amount are severance costs associated with our global reduction-in-force programs.

19

The following table presents our unaudited non‑GAAP net income and non-GAAP diluted EPS and a reconciliation from net income, the most comparable GAAP measure, for the periods indicated:

	Three Months Ended
	March 31, 2023		April 1, 2022
	(dollars in thousands, except per share amounts)
U.S. GAAP net income (loss)	$	(5)	$	8,039
Non-GAAP adjustments:
Amortization of intangible assets	3,966		5,349
Share-based compensation	3,637		2,897
Settlement loss (1)	—		3,100
Fair value adjustment to inventory from acquisitions (2)	—		2,492
Acquisition costs (3)	—		275
Other (4)	1,324		—
Tax adjustments related to non-GAAP adjustments (5)	2,206		(1,974)
Non-GAAP net income	$	11,128	$	20,178
U.S. GAAP diluted EPS	$	0.00	$	0.28
Non-GAAP diluted EPS	$	0.38	$	0.70
Shares used to compute non-GAAP diluted EPS	29,412,185		29,023,455

(1)During the first quarter of 2022, we recorded a loss accrual of $3.1 million relating to an expected settlement of an employment-related legal matter. We expect the settlement to be finalized and paid in 2023.

(2)As part of the purchase price allocation of our acquisition of IMG, we recorded acquired-inventories at fair value, resulting in a fair value step-up. This amount represents the release of the step-up to cost of sales as acquired-inventories were sold.

(3)Included in this amount are transaction-related costs incurred in connection with our acquisition of IMG.

(4)Included in this amount are severance costs associated with our global reduction-in-force programs.

(5)Adjusts U.S. GAAP income tax expense for impact of our non-GAAP adjustments, as defined, including the impacts of excluding share-based compensation and amortization of intangible assets. Additionally, this adjustment excludes the impact of non-recurring discrete tax items.

Liquidity and Capital Resources

The following section discusses our liquidity and capital resources, including our primary sources of liquidity and our material cash requirements. Our cash and cash equivalents are maintained in highly liquid and accessible accounts with no significant restrictions.

Material Cash Requirements

Our primary liquidity requirements arise from: (i) working capital requirements, including procurement of raw materials inventory for use in our factories and employee-related costs, (ii) business acquisitions, (iii) interest and principal payments under our credit facilities, (iv) research and development investments and capital expenditures, and (v) payment of income taxes. We have no significant long-term purchase commitments related to procuring raw materials inventory. Our ability to fund these requirements will depend, in part, on our future cash flows, which are determined by our future operating performance and are therefore subject to prevailing global macroeconomic conditions and financial, business, and other factors, some of which are beyond our control.

20

We believe that our cash and cash equivalents, the amounts available under our credit facilities, and our operating cash flow will be sufficient to fund our business and our current obligations for at least the next 12 months and beyond.

Sources and Conditions of Liquidity

Our ongoing sources of liquidity to fund our material cash requirements are primarily derived from: (i) sales to our customers and the related changes in our net operating assets and liabilities and (ii) proceeds from our credit facilities and equity offerings, when applicable.

Summary of Cash Flows

We ended the first quarter of 2023 with cash and cash equivalents of $68.8 million, a decrease of $17.6 million from the prior year ended December 30, 2022. The decrease of $17.6 million during the first quarter was primarily due to net cash used in operating activities of $10.9 million and capital expenditures of $6.8 million.

The following table sets forth a summary of operating, investing, and financing activities for the periods presented:

	Three Months Ended
	March 31, 2023		April 1, 2022
	(in thousands)
Cash used in operating activities	$	(10,873)	$	(36,278)
Cash used in investing activities	(6,819)		(3,417)
Cash provided by (used in) financing activities	59		(1,284)
Net decrease in cash	$	(17,633)	$	(40,979)

Our cash used in operating activities of $10.9 million during the first quarter consisted of net loss of $0.0 million, net non-cash charges of $11.2 million, consisting primarily of depreciation and amortization of $8.5 million and share-based compensation expense of $3.6 million, and an increase in our net operating assets and liabilities of $22.1 million.

The increase in our net operating assets and liabilities of $22.1 million during the first quarter was primarily due to a decrease in accounts payable of $43.0 million, which was primarily due to the timing of inventory purchases and receipts, partially offset by a decrease in accounts receivable of $13.6 million and a decrease in inventories of $12.1 million.

Cash used in investing activities during the first quarter of 2023 and 2022 consisted of capital expenditures.

Cash provided by financing activities during the first quarter of 2023 and 2022 consisted of net proceeds from share-based compensation activity of $1.9 million and $0.6 million, respectively, partially offset by term loan payments of $1.9 million.

Critical Accounting Estimates

Our consolidated financial statements have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, sales, expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results may differ from these estimates. To the extent that there are material differences between these estimates and our actual results, our future financial statements will be affected.

The critical accounting policies requiring estimates, assumptions, and judgments that we believe have the most significant impact on our consolidated financial statements are identified and described in our annual consolidated financial statements and the notes included in our 2022 Annual Report on Form 10‑K.

21

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign Currency Exchange Risk

Substantially all of our sales arrangement with customers, and the significant majority of our arrangements with third-party suppliers, provide for pricing and payment in U.S. dollars and, therefore, are not subject to material exchange rate fluctuations. As a result, we do not expect foreign currency exchange rate fluctuations to have a material effect on our results of operations. However, increases in the value of the U.S. dollar relative to other currencies would make our products more expensive relative to competing products priced in such other currencies, which could negatively impact our ability to compete. Conversely, decreases in the value of the U.S. dollar relative to other currencies could result in our foreign suppliers raising their prices in order to continue doing business with us.

We have certain operating expenses that are denominated in currencies of the countries in which our operations are located, and may be subject to fluctuations due to foreign currency exchange rates, particularly the Singapore dollar, Malaysian ringgit, British pound, euro, Korean won, and Mexican peso. Fluctuations in foreign currency exchange rates may cause us to recognize transaction gains and losses in our statement of operations. To date, foreign currency transaction gains and losses have not been material to our financial statements, and we have not engaged in any foreign currency hedging transactions.

Interest Rate Risk

We had total indebtedness of $300.6 million as of March 31, 2023, exclusive of $1.7 million in debt issuance costs, of which $7.5 million was due within 12 months. We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure. We have not been, nor do we anticipate being exposed to, material risks due to changes in interest rates. As of March 31, 2023, the interest rate on our outstanding debt is based on BSBY, plus an applicable rate depending on our leverage ratio. A hypothetical 100 basis point change in the interest rate on our outstanding debt would have resulted in a $0.8 million change to interest expense during the quarter, or $3.0 million on an annualized basis.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer (the certifying officers), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a‑15(e) and 15d‑15(e) under the Securities and Exchange Act, as amended (“the Exchange Act”)) as of December 30, 2022. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based on this evaluation, our certifying officers concluded that our disclosure controls and procedures were not effective as of March 31, 2023, due to a material weakness in internal control over financial reporting that was disclosed in Part II – Item 9A of our 2022 Annual Report on Form 10‑K.

Limitations on Effectiveness of Controls and Procedures

A company’s internal control over financial reporting is a process designed by, or under the supervision of, a company’s principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate. If we cannot provide reliable financial information, our business, operating results, and share price could be negatively impacted.

22

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the period covered under this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Remediation

As previously described in Part II – Item 9A, Controls and Procedures of our Annual Report on Form 10‑K for the fiscal year ended December 30, 2022, we are implementing a remediation plan to address the material weakness mentioned above. The weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We expect the remediation of the material weakness to be completed prior to the end of fiscal year 2023.

23

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are currently not a party to any material pending or threatened litigation.

ITEM 1A. RISK FACTORS

This quarterly report should be read in conjunction with the risk factors included in our 2022 Annual Report on Form 10‑K. There have been no material changes in our risk factors from the risk factors disclosed in that report. These risk factors do not identify all risks that we face – our operations could also be affected by factors that are not presently known to us or that we currently consider to be immaterial to our operations. Due to risks and uncertainties, known and unknown, our past financial results may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit Number	Description
31.1*	Certification of Principal Executive Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
31.2*	Certification of Principal Financial Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
32.1**	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
32.2**	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
101.INS*	Inline XBRL Instance Document
101.SCH*	Inline XBRL Taxonomy Extension Schema Document
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

*Filed herewith.

**Furnished herewith and not filed.

24

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ICHOR HOLDINGS, LTD.
Date: May 10, 2023	By:	/s/ Jeffrey S. Andreson
		Jeffrey S. Andreson
		Chief Executive Officer (Principal Executive Officer)
Date: May 10, 2023	By:	/s/ Larry J. Sparks
		Larry J. Sparks
		Chief Financial Officer (Principal Accounting and Financial Officer)

25

EX-31.1

Exhibit 31.1

CEO CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jeffrey S. Andreson, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Ichor Holdings, Ltd.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a‑15(f) and 15d‑15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 10, 2023	By:	/s/ Jeffrey S. Andreson
		Jeffrey S. Andreson
		Chief Executive Officer

EX-31.2

Exhibit 31.2

CFO CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Larry J. Sparks, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Ichor Holdings, Ltd.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a‑15(f) and 15d‑15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 10, 2023	By:	/s/ Larry J. Sparks
		Larry J. Sparks
		Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ichor Holdings, Ltd. (the “Company”) on Form 10-Q for the period ending March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, to my knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes‑Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 10, 2023	By:	/s/ Jeffrey S. Andreson
		Jeffrey S. Andreson
		Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ichor Holdings, Ltd. (the “Company”) on Form 10-Q for the period ending March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, to my knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes‑Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 10, 2023	By:	/s/ Larry J. Sparks
		Larry J. Sparks
		Chief Financial Officer

XML

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 05, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-37961
Entity Registrant Name	ICHOR HOLDINGS, LTD.
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	3185 Laurelview Ct.
Entity Address, City or Town	Fremont
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94538
City Area Code	510
Local Phone Number	897-5200
Title of 12(b) Security	Ordinary Shares, par value $0.0001
Trading Symbol	ICHR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Ordinary Shares Outstanding		29,055,904
Entity Central Index Key	0001652535
Current Fiscal Year End Date	--12-29
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Tax Identification Number	00-0000000

XML

Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 68,837,000	$ 86,470,000
Accounts receivable, net	122,693,000	136,321,000
Inventories	271,538,000	283,660,000
Prepaid expenses and other current assets	6,530,000	7,007,000
Total current assets	469,598,000	513,458,000
Property and equipment, net	101,481,000	98,055,000
Operating lease right-of-use assets	40,609,000	40,557,000
Other noncurrent assets	12,660,000	12,926,000
Deferred tax assets, net	12,345,000	11,322,000
Intangible assets, net	68,056,000	72,022,000
Goodwill	335,402,000	335,402,000
Total assets	1,040,151,000	1,083,742,000
Current liabilities:
Accounts payable	68,030,000	110,165,000
Accrued liabilities	21,417,000	23,616,000
Other current liabilities	11,821,000	15,815,000
Current portion of long-term debt	7,500,000	7,500,000
Current portion of lease liabilities	9,457,000	9,196,000
Total current liabilities	118,225,000	166,292,000
Long-term debt, less current portion, net	291,459,000	293,218,000
Lease liabilities, less current portion	31,988,000	31,828,000
Deferred tax liabilities, net	29,000	29,000
Other non-current liabilities	4,986,000	4,879,000
Total liabilities	446,687,000	496,246,000
Shareholders’ equity:
Preferred shares ($0.0001 par value; 20,000,000 shares authorized; 0 shares issued and outstanding)	0	0
Ordinary shares ($0.0001 par value; 200,000,000 shares authorized; 29,034,946 and 28,861,949 shares outstanding, respectively; 33,472,385 and 33,299,388 shares issued, respectively)	3,000	3,000
Additional paid in capital	437,388,000	431,415,000
Treasury shares at cost (4,437,439 shares)	(91,578,000)	(91,578,000)
Retained earnings	247,651,000	247,656,000
Total shareholders’ equity	593,464,000	587,496,000
Total liabilities and shareholders’ equity	$ 1,040,151,000	$ 1,083,742,000

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred shares, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred shares, authorized (in shares)	20,000,000	20,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Ordinary shares, par value (in usd per share)	$ 0.0001	$ 0.0001
Ordinary shares, authorized (in shares)	200,000,000	200,000,000
Ordinary shares, outstanding (in shares)	29,034,946	28,861,949
Ordinary shares, issued (in shares)	33,472,385	33,299,388
Treasury stock, shares (in shares)	4,437,439	4,437,439

XML

Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net sales	$ 225,870	$ 293,146
Cost of sales	192,630	249,214
Gross profit	33,240	43,932
Operating expenses:
Research and development	4,313	4,851
Selling, general, and administrative	20,167	23,267
Amortization of intangible assets	3,966	5,349
Total operating expenses	28,446	33,467
Operating income	4,794	10,465
Interest expense, net	4,550	1,532
Other expense, net	784	84
Income (loss) before income taxes	(540)	8,849
Income tax expense (benefit)	(535)	810
Net income (loss)	$ (5)	$ 8,039
Net income (loss) per share
Net income per share, basic (in usd per share)	$ 0.00	$ 0.28
Net income per share, diluted (in usd per share)	$ 0.00	$ 0.28
Shares used to compute Net income (loss) per share:
Shares used to compute net income per share, basic (in shares)	28,984,878	28,592,629
Shares used to compute net income per share, diluted (in shares)	28,984,878	29,023,455

XML

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Ordinary Shares	Additional Paid-In Capital	Treasury Shares	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021		28,551,160
Beginning balance at Dec. 31, 2021	$ 500,715	$ 3	$ 417,438		$ 174,852
Treasury stock, beginning balance (in shares) at Dec. 31, 2021				4,437,439
Treasury stock, beginning balance at Dec. 31, 2021				$ (91,578)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ordinary shares issued from exercise of stock options (in shares)		42,753
Ordinary shares issued from exercise of stock options	955		955
Ordinary shares issued from vesting of restricted share units (in shares)		34,994
Ordinary shares issued from vesting of restricted share units	(777)		(777)
Share-based compensation expense	2,897		2,897
Net income (loss)	8,039				8,039
Ending balance (in shares) at Mar. 31, 2022		28,628,907
Ending balance at Mar. 31, 2022	511,829	$ 3	420,513		182,891
Treasury stock, ending balance (in shares) at Mar. 31, 2022				4,437,439
Treasury stock, ending balance at Mar. 31, 2022				$ (91,578)
Beginning balance (in shares) at Dec. 31, 2022		28,861,949
Beginning balance at Dec. 31, 2022	587,496	$ 3	431,415		247,656
Treasury stock, beginning balance (in shares) at Dec. 31, 2022				4,437,439
Treasury stock, beginning balance at Dec. 31, 2022				$ (91,578)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ordinary shares issued from exercise of stock options (in shares)		92,766
Ordinary shares issued from exercise of stock options	2,126		2,126
Ordinary shares issued from vesting of restricted share units (in shares)		32,527
Ordinary shares issued from vesting of restricted share units	(692)		(692)
Ordinary shares issued from employee share purchase plan (in shares)		47,704
Ordinary shares issued from employee share purchase plan	902		902
Share-based compensation expense	3,637		3,637
Net income (loss)	(5)				(5)
Ending balance (in shares) at Mar. 31, 2023		29,034,946
Ending balance at Mar. 31, 2023	$ 593,464	$ 3	$ 437,388		$ 247,651
Treasury stock, ending balance (in shares) at Mar. 31, 2023				4,437,439
Treasury stock, ending balance at Mar. 31, 2023				$ (91,578)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (5)	$ 8,039
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	8,489	9,315
Share-based compensation	3,637	2,897
Deferred income taxes	(1,023)	(37)
Amortization of debt issuance costs	116	117
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net	13,628	(10,544)
Inventories	12,122	(27,718)
Prepaid expenses and other assets	2,705	(650)
Accounts payable	(43,018)	(18,209)
Accrued liabilities	(1,797)	2,182
Other liabilities	(5,727)	(1,670)
Net cash used in operating activities	(10,873)	(36,278)
Cash flows from investing activities:
Capital expenditures	(6,819)	(3,417)
Net cash used in investing activities	(6,819)	(3,417)
Cash flows from financing activities:
Issuance of ordinary shares under share-based compensation plans	2,626	1,368
Employees' taxes paid upon vesting of restricted share units	(692)	(777)
Repayments on term loan	(1,875)	(1,875)
Net cash provided by (used in) financing activities	59	(1,284)
Net decrease in cash	(17,633)	(40,979)
Cash at beginning of period	86,470	75,495
Cash at end of period	68,837	34,516
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	4,745	1,395
Cash paid during the period for taxes, net of refunds	104	106
Supplemental disclosures of non-cash activities:
Capital expenditures included in accounts payable	2,426	2,278
Right-of-use assets obtained in exchange for new operating lease liabilities, including those acquired through acquisitions	$ 2,261	$ 6,067

XML

Basis of Presentation and Selected Significant Accounting Policies

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation and Selected Significant Accounting Policies

Note 1 – Basis of Presentation and Selected Significant Accounting Policies

Basis of Presentation

These consolidated unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”). All intercompany balances and transactions have been eliminated upon consolidation. All dollar figures presented in tables in the notes to consolidated financial statements are in thousands, except per share amounts. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10‑K for the year ended December 30, 2022.

Year End

We use a 52- or 53-week fiscal year ending on the last Friday in December. Our fiscal years ending December 29, 2023 and December 30, 2022 each are 52 weeks. References to 2023 and 2022 relate to the fiscal years then ended. The three-month periods ended March 31, 2023 and April 1, 2022 each are 13 weeks. References to the first quarter of 2023 and 2022 relate to the three-month periods then ended.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods presented. We base our estimates and judgments on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results could differ from the estimates made by management. Significant estimates include inventory valuation and impairment analysis for both definite‑lived intangible assets and goodwill.

Cash and Cash Equivalents

Cash and cash equivalents consist of deposits and financial instruments which are readily convertible into cash and have original maturities of 90 days or less at the time of acquisition.

Fair Value of Financial Instruments

The carrying values of our financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued liabilities, and long-term debt, net of unamortized debt issuance costs, approximate fair value.

Revenue Recognition

We recognize revenue when control of promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. This amount is recorded as net sales in our consolidated statements of operations.

Transaction price – In most of our contracts, prices are generally determined by a customer-issued purchase order and generally remain fixed over the duration of the contract. Certain contracts contain variable consideration, including early-payment discounts and rebates. When a contract includes variable consideration, we evaluate the estimate of the variable consideration to determine whether the estimate needs to be constrained; therefore, we include the variable consideration in the transaction price only to the extent that it is probable that a significant reversal will not occur. Variable consideration estimates are updated at each reporting date. Historically, we have not incurred significant costs to obtain a contract. All amounts billed to a customer relating to shipping and handling are classified as net sales, while all costs incurred by us for shipping and handling are classified as cost of sales.

Performance obligations – Substantially all of our performance obligations pertain to promised goods (“products”), which are primarily comprised of fluid delivery subsystems, weldments, and other components. Most of our contracts contain a single performance obligation and are generally completed within twelve months. Product sales are recognized at a point-in-time, generally upon delivery, as such term is defined within the contract, as that is when control of the promised good has transferred. Products are covered by a standard assurance warranty, generally extended for a period of one to two years depending on the customer, which promises that delivered products conform to contract specifications. As such, we account for such warranties under ASC 460, Guarantees, and not as a separate performance obligation.

Contract balances – Accounts receivable represents our unconditional right to receive consideration from our customers. Accounts receivable are carried at invoice price less an estimate for doubtful accounts and estimated payment discounts. Payment terms vary by customer but are generally due within 15-60 days. Historically, we have not incurred significant payment issues with our customers. We had no significant contract assets or liabilities on our consolidated balance sheets in any of the periods presented.

Accounting Pronouncements Recently Adopted

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021‑08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. We adopted the ASU on the first day of 2023 and it did not have a material impact on our consolidated financial statements.

XML

Inventories

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Inventories

Note 2 – Inventories

Inventories consist of the following:

	March 31, 2023		December 30, 2022
Raw materials	$	196,504	$	197,726
Work in process	39,733		56,291
Finished goods	54,306		47,186
Excess and obsolete adjustment	(19,005)		(17,543)
Total inventories	$	271,538	$	283,660

XML

Property and Equipment and Other Noncurrent Assets

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Property and Equipment and Other Noncurrent Assets

Note 3 – Property and Equipment and Other Noncurrent Assets

Property and equipment consist of the following:

	March 31, 2023		December 30, 2022
Machinery	$	96,338	$	90,507
Leasehold improvements	43,556		43,129
Computer software, hardware, and equipment	10,053		9,664
Office furniture, fixtures, and equipment	1,354		1,337
Vehicles	401		401
Construction-in-process	21,510		19,869
	173,212		164,907
Less accumulated depreciation	(71,731)		(66,852)
Total property and equipment, net	$	101,481	$	98,055

Depreciation expense was $4.3 million and $4.0 million for the first quarter of 2023 and 2022, respectively.

Cloud Computing Implementation Costs

We capitalize implementation costs associated with hosting arrangement that are service contracts. These costs are recorded to prepaid expenses or other noncurrent assets. To-date, these costs are those incurred to implement a new company-wide ERP system. The balance of capitalized cloud computing implementation costs, net of accumulated amortization, was $11.4 million and $11.6 million as of March 31, 2023 and December 30, 2022, respectively, and is included in other assets on our consolidated balance sheets. The related amortization expense was $0.2 million and $0.2 million during the first quarter of 2023 and 2022, respectively, and is included in selling, general, and administrative expense on our consolidated statements of operations.

XML

Intangible Assets

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 4 – Intangible Assets

Definite‑lived intangible assets consist of the following:

	March 31, 2023
	Gross value		Accumulated amortization		Accumulated impairment charges		Carrying amount		Weighted average useful life
Customer relationships	117,022		(55,202)		—		61,820		8.4 years
Developed technology	11,047		(4,811)		—		6,236		10.0 years
Total intangible assets	$	128,069	$	(60,013)	$	—	$	68,056

	December 30, 2022
	Gross value		Accumulated amortization		Accumulated impairment charges		Carrying amount		Weighted average useful life
Customer relationships	117,022		(51,337)		—		65,685		8.4 years
Developed technology	11,047		(4,710)		—		6,337		10.0 years
Total intangible assets	$	128,069	$	(56,047)	$	—	$	72,022

XML

Leases

3 Months Ended

Mar. 31, 2023

Leases [Abstract]

Leases

Note 5 – Leases

Operating lease right-of-use (“ROU”) assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating operating lease ROU assets and operating lease liabilities, we use the non-cancelable lease term plus options to extend that we are reasonably certain to take. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. Our leases generally do not provide an implicit rate. As such, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

We lease facilities under various non-cancelable operating leases expiring through 2031. In addition to base rental payments, we are generally responsible for our proportionate share of operating expenses, including facility maintenance, insurance, and property taxes. As these amounts are variable, they are not included in lease liabilities.

The components of lease expense are as follows:

	Three Months Ended
	March 31, 2023		April 1, 2022
Operating lease cost	$	2,411	$	2,045

Supplemental cash flow information related to leases is as follows:

	Three Months Ended
	March 31, 2023		April 1, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,237	$	1,823

Supplemental balance sheet information related to leases is as follows:

	March 31, 2023	December 30, 2022
Weighted-average remaining lease term of operating leases	5.2 years	5.3 years
Weighted-average discount rate of operating leases	3.2%	3.0%

Future minimum lease payments under non-cancelable leases are as follows as of March 31, 2023:

2023, remaining	$	7,117
2024	9,074
2025	8,418
2026	7,968
2027	6,968
Thereafter	5,367
Total future minimum lease payments	44,912
Less imputed interest	(3,467)
Total lease liabilities	$	41,445

XML

Income Taxes

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

Note 6 – Income Taxes

Income tax information for the periods reported is as follows:

	Three Months Ended
	March 31, 2023			April 1, 2022
Income tax expense (benefit)	$	(535)		$	810
Income (loss) before income taxes	$	(540)		$	8,849
Effective income tax rate	99.1		%	9.2		%

Our effective tax rates for the three months ended March 31, 2023 and April 1, 2022 differ from the statutory rate primarily due to taxes on foreign income that differ from the U.S. tax rate, including a tax holiday in Singapore. Our effective tax rate of 99.1% for the first quarter of 2023 is primarily due to projected pre-tax loss in the U.S. for 2023, which generates tax benefits, partially offset by projected pre-tax income in Singapore, our primary source of non-U.S. pre-tax income and for which we participate in a tax holiday through 2026.

The ending balance for the unrecognized tax benefits for uncertain tax positions was approximately $4.5 million at March 31, 2023. The related interest and penalties were insignificant. The uncertain tax positions that are reasonably possible to decrease in the next twelve months are insignificant.

As of March 31, 2023, we were under examination by the Inland Revenue Board of Malaysia for the years 2016 to 2020.

XML

Employee Benefit Programs

3 Months Ended

Mar. 31, 2023

Retirement Benefits [Abstract]

Employee Benefit Programs

Note 7 – Employee Benefit Programs

401(k) Plan

We sponsor a 401(k) plan available to employees of our U.S.‑based subsidiaries. Participants may make salary deferral contributions not to exceed 50% of a participant’s annual compensation or the maximum amount otherwise allowed by law. Eligible employees receive a discretionary matching contribution equal to 50% of a participant’s deferral, up to an annual matching maximum of 4% of a participant’s annual compensation. Matching contributions were $0.9 million and $1.0 million for the first quarter of 2023 and 2022, respectively.

XML

Long-Term Debt

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Long-Term Debt

Note 8 – Long-Term Debt

Long‑term debt consists of the following:

	March 31, 2023		December 30, 2022
Term loan	$	140,625	$	142,500
Revolving credit facility	160,000		160,000
Total principal amount of long-term debt	300,625		302,500
Less unamortized debt issuance costs	(1,666)		(1,782)
Total long-term debt, net	298,959		300,718
Less current portion	(7,500)		(7,500)
Total long-term debt, less current portion, net	$	291,459	$	293,218

On October 29, 2021, we entered into an amended and restated credit agreement, which includes a group of financial institutions as direct lenders underlying the agreement. The credit agreement includes a $150.0 million term loan facility and a $250.0 million revolving credit facility (together, “credit facilities”). Term loan principal payments of $1.9 million are due on a quarterly basis. The credit facilities mature on October 29, 2026.

Interest is charged at either the Base Rate or the Bloomberg Short-Term Bank Yield (“BSBY”) Rate (as such terms are defined in the credit agreement) at our option, plus an applicable margin. The Base Rate is equal to the higher of i) the Prime Rate, ii) the Federal Funds Rate plus 0.5%, or iii) the BSBY Rate plus 1.00%. The applicable margin on Base Rate and BSBY Rate loans is 0.375-1.375% and 1.375-2.375% per annum, respectively, depending on our leverage ratio, which is based on trailing 12-month EBITDA, as defined in our credit agreement. We are also charged a commitment fee of 0.175%-0.350%, depending on our leverage ratio, on the unused portion of our revolving credit facility. Base Rate interest payments and commitment fees are due quarterly. BSBY Rate interest payments are due on the last day of the applicable interest period, or quarterly for applicable interest periods longer than 3 months. At March 31, 2023, our credit facilities bore interest under the BSBY rate option of 6.51%.

XML

Share-Based Compensation

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Share-Based Compensation

Note 9 – Share‑Based Compensation

The 2016 Omnibus Incentive Plan (the “2016 Plan”) provides for grants of share‑based awards to employees, directors, and consultants. Awards may be in the form of stock options (“options”), tandem and non‑tandem stock appreciation rights, restricted share awards or restricted share units (“RSUs”), performance awards, and other share‑based awards. Forfeited or expired awards are returned to the incentive plan pool for future grants. Awards generally vest over four years, 25% on the first anniversary of the date of grant and quarterly thereafter over the remaining 3 years. Upon vesting of RSUs, shares are withheld to cover statutory minimum withholding taxes. Shares withheld are not reflected as an issuance of ordinary shares within our consolidated statements of shareholders’ equity, as the shares were never issued, and the associated tax payments are reflected as financing activities within our consolidated statements of cash flows.

Share‑based compensation expense across all plans for options, RSUs, and employee share purchase rights was $3.6 million and $2.9 million for the first quarter of 2023 and 2022.

Stock Options

The following table summarizes option activity:

	Number of Stock Options
	Service condition	Weighted average exercise price per share		Weighted average remaining contractual term	Aggregate intrinsic value
Outstanding, December 30, 2022	805,115	$	23.35
Granted	—	$	0.00
Exercised	(92,766)	$	22.91
Forfeited or expired	(1,444)	$	22.18
Outstanding, March 31, 2023	710,905	$	23.41	2.6 years	$	6,634
Exercisable, March 31, 2023	634,134	$	23.36	2.4 years	$	5,951

Restricted Share Units

The following table summarizes RSU activity:

	Number of Restricted Share Units
	Service condition	Performance condition	Market condition	Weighted average grant-date fair value per share
Unvested, December 30, 2022	860,595	57,562	86,342	$	30.26
Granted	69,675	—	—	$	27.04
Vested	(51,938)	—	—	$	33.57
Forfeited	(11,936)	—	—	$	31.81
Unvested, March 31, 2023	866,396	57,562	86,342	$	29.78

Employee Share Purchase Plan

The 2017 Employee Stock Purchase Plan (the “2017 ESPP”) grants employees the ability to designate a portion of their base-pay to purchase ordinary shares at a price equal to 85% of the fair market value of our ordinary shares on the first or last day of each 6 month purchase period. Purchase periods begin on January 1 or July 1 and end on June 30 or December 31, or the next business day if such date is not a business day. Shares are purchased on the last day of the purchase period.

As of March 31, 2023, approximately 2.2 million ordinary shares remain available for purchase under the 2017 ESPP.

XML

Earnings per Share

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Earnings per Share

Note 10 – Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share and a reconciliation of the numerator and denominator used in the calculation:

	Three Months Ended
	March 31, 2023		April 1, 2022
Numerator:
Net income (loss)	$	(5)	$	8,039
Denominator:
Basic weighted average ordinary shares outstanding	28,984,878		28,592,629
Dilutive effect of options	—		292,828
Dilutive effect of RSUs	—		135,860
Dilutive effect of ESPP	—		2,138
Diluted weighted average ordinary shares outstanding	28,984,878		29,023,455
Securities excluded from the calculation of diluted weighted average ordinary shares outstanding (1)	1,879,000		267,000
Net income (loss) per share:
Basic	$	0.00	$	0.28
Diluted	$	0.00	$	0.28

(1)Represents potentially dilutive options and RSUs excluded from the calculation of diluted weighted average ordinary shares outstanding, because including them would have been antidilutive under the treasury stock method.

XML

Segment Information

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Segment Information

Note 11 – Segment Information

Our Chief Operating Decision Maker, the Chief Executive Officer, reviews our results of operations on a consolidated level and executive staff is structured by function rather than by product category. Additionally, key resources, decisions, and assessment of performance are analyzed at a company‑wide level. Therefore, we operate in one operating segment.

Foreign operations are conducted primarily through our wholly owned subsidiaries in Singapore and Malaysia, and to a lesser degree, Scotland, Korea, and Mexico. Our principal markets include North America, Asia, and to a lesser degree, Europe.

Sales by geographic area represents sales to unaffiliated customers based upon the location to which the products were shipped. The following table sets forth sales by geographic area:

	Three Months Ended
	March 31, 2023		April 1, 2022
United States of America	$	89,052	$	142,470
Singapore	82,286		103,295
Europe	29,986		24,392
Other	24,546		22,989
Total net sales	$	225,870	$	293,146

Foreign long-lived assets, exclusive of deferred tax assets, were $52.5 million and $52.8 million at March 31, 2023 and December 30, 2022, respectively.

XML

Basis of Presentation and Selected Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

These consolidated unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”). All intercompany balances and transactions have been eliminated upon consolidation. All dollar figures presented in tables in the notes to consolidated financial statements are in thousands, except per share amounts. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10‑K for the year ended December 30, 2022.

Year End

Year End

We use a 52- or 53-week fiscal year ending on the last Friday in December. Our fiscal years ending December 29, 2023 and December 30, 2022 each are 52 weeks. References to 2023 and 2022 relate to the fiscal years then ended. The three-month periods ended March 31, 2023 and April 1, 2022 each are 13 weeks. References to the first quarter of 2023 and 2022 relate to the three-month periods then ended.

Use of Estimates

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods presented. We base our estimates and judgments on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results could differ from the estimates made by management. Significant estimates include inventory valuation and impairment analysis for both definite‑lived intangible assets and goodwill.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents consist of deposits and financial instruments which are readily convertible into cash and have original maturities of 90 days or less at the time of acquisition.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The carrying values of our financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued liabilities, and long-term debt, net of unamortized debt issuance costs, approximate fair value.

Revenue Recognition

Revenue Recognition

We recognize revenue when control of promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. This amount is recorded as net sales in our consolidated statements of operations.

Transaction price – In most of our contracts, prices are generally determined by a customer-issued purchase order and generally remain fixed over the duration of the contract. Certain contracts contain variable consideration, including early-payment discounts and rebates. When a contract includes variable consideration, we evaluate the estimate of the variable consideration to determine whether the estimate needs to be constrained; therefore, we include the variable consideration in the transaction price only to the extent that it is probable that a significant reversal will not occur. Variable consideration estimates are updated at each reporting date. Historically, we have not incurred significant costs to obtain a contract. All amounts billed to a customer relating to shipping and handling are classified as net sales, while all costs incurred by us for shipping and handling are classified as cost of sales.

Performance obligations – Substantially all of our performance obligations pertain to promised goods (“products”), which are primarily comprised of fluid delivery subsystems, weldments, and other components. Most of our contracts contain a single performance obligation and are generally completed within twelve months. Product sales are recognized at a point-in-time, generally upon delivery, as such term is defined within the contract, as that is when control of the promised good has transferred. Products are covered by a standard assurance warranty, generally extended for a period of one to two years depending on the customer, which promises that delivered products conform to contract specifications. As such, we account for such warranties under ASC 460, Guarantees, and not as a separate performance obligation.

Contract balances – Accounts receivable represents our unconditional right to receive consideration from our customers. Accounts receivable are carried at invoice price less an estimate for doubtful accounts and estimated payment discounts. Payment terms vary by customer but are generally due within 15-60 days. Historically, we have not incurred significant payment issues with our customers. We had no significant contract assets or liabilities on our consolidated balance sheets in any of the periods presented.

Accounting Pronouncements Recently Adopted

Accounting Pronouncements Recently Adopted

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021‑08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. We adopted the ASU on the first day of 2023 and it did not have a material impact on our consolidated financial statements.

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consist of the following:

	March 31, 2023		December 30, 2022
Raw materials	$	196,504	$	197,726
Work in process	39,733		56,291
Finished goods	54,306		47,186
Excess and obsolete adjustment	(19,005)		(17,543)
Total inventories	$	271,538	$	283,660

XML

Property and Equipment and Other Noncurrent Assets (Tables)

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Summary of Property and Equipment

Property and equipment consist of the following:

	March 31, 2023		December 30, 2022
Machinery	$	96,338	$	90,507
Leasehold improvements	43,556		43,129
Computer software, hardware, and equipment	10,053		9,664
Office furniture, fixtures, and equipment	1,354		1,337
Vehicles	401		401
Construction-in-process	21,510		19,869
	173,212		164,907
Less accumulated depreciation	(71,731)		(66,852)
Total property and equipment, net	$	101,481	$	98,055

XML

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Definite-Lived Intangible Assets

Definite‑lived intangible assets consist of the following:

	March 31, 2023
	Gross value		Accumulated amortization		Accumulated impairment charges		Carrying amount		Weighted average useful life
Customer relationships	117,022		(55,202)		—		61,820		8.4 years
Developed technology	11,047		(4,811)		—		6,236		10.0 years
Total intangible assets	$	128,069	$	(60,013)	$	—	$	68,056

	December 30, 2022
	Gross value		Accumulated amortization		Accumulated impairment charges		Carrying amount		Weighted average useful life
Customer relationships	117,022		(51,337)		—		65,685		8.4 years
Developed technology	11,047		(4,710)		—		6,337		10.0 years
Total intangible assets	$	128,069	$	(56,047)	$	—	$	72,022

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2023

Leases [Abstract]

Components of Lease Expense

The components of lease expense are as follows:

	Three Months Ended
	March 31, 2023		April 1, 2022
Operating lease cost	$	2,411	$	2,045

Supplemental Cash Flow Information Related to Leases

Supplemental cash flow information related to leases is as follows:

	Three Months Ended
	March 31, 2023		April 1, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,237	$	1,823

Supplemental Balance Sheet Information Related to Leases

Supplemental balance sheet information related to leases is as follows:

	March 31, 2023	December 30, 2022
Weighted-average remaining lease term of operating leases	5.2 years	5.3 years
Weighted-average discount rate of operating leases	3.2%	3.0%

Future Minimum Lease Payments Under Non-Cancelable Leases

Future minimum lease payments under non-cancelable leases are as follows as of March 31, 2023:

2023, remaining	$	7,117
2024	9,074
2025	8,418
2026	7,968
2027	6,968
Thereafter	5,367
Total future minimum lease payments	44,912
Less imputed interest	(3,467)
Total lease liabilities	$	41,445

XML

Income Taxes (Tables)

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Income Taxes

Income tax information for the periods reported is as follows:

	Three Months Ended
	March 31, 2023			April 1, 2022
Income tax expense (benefit)	$	(535)		$	810
Income (loss) before income taxes	$	(540)		$	8,849
Effective income tax rate	99.1		%	9.2		%

XML

Long-Term Debt (Tables)

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Schedule of Long-term Debt

Long‑term debt consists of the following:

	March 31, 2023		December 30, 2022
Term loan	$	140,625	$	142,500
Revolving credit facility	160,000		160,000
Total principal amount of long-term debt	300,625		302,500
Less unamortized debt issuance costs	(1,666)		(1,782)
Total long-term debt, net	298,959		300,718
Less current portion	(7,500)		(7,500)
Total long-term debt, less current portion, net	$	291,459	$	293,218

XML

Share-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Option Activity

The following table summarizes option activity:

	Number of Stock Options
	Service condition	Weighted average exercise price per share		Weighted average remaining contractual term	Aggregate intrinsic value
Outstanding, December 30, 2022	805,115	$	23.35
Granted	—	$	0.00
Exercised	(92,766)	$	22.91
Forfeited or expired	(1,444)	$	22.18
Outstanding, March 31, 2023	710,905	$	23.41	2.6 years	$	6,634
Exercisable, March 31, 2023	634,134	$	23.36	2.4 years	$	5,951

Schedule of RSU Activity

The following table summarizes RSU activity:

	Number of Restricted Share Units
	Service condition	Performance condition	Market condition	Weighted average grant-date fair value per share
Unvested, December 30, 2022	860,595	57,562	86,342	$	30.26
Granted	69,675	—	—	$	27.04
Vested	(51,938)	—	—	$	33.57
Forfeited	(11,936)	—	—	$	31.81
Unvested, March 31, 2023	866,396	57,562	86,342	$	29.78

XML

Earnings per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share and a reconciliation of the numerator and denominator used in the calculation:

	Three Months Ended
	March 31, 2023		April 1, 2022
Numerator:
Net income (loss)	$	(5)	$	8,039
Denominator:
Basic weighted average ordinary shares outstanding	28,984,878		28,592,629
Dilutive effect of options	—		292,828
Dilutive effect of RSUs	—		135,860
Dilutive effect of ESPP	—		2,138
Diluted weighted average ordinary shares outstanding	28,984,878		29,023,455
Securities excluded from the calculation of diluted weighted average ordinary shares outstanding (1)	1,879,000		267,000
Net income (loss) per share:
Basic	$	0.00	$	0.28
Diluted	$	0.00	$	0.28

(1)Represents potentially dilutive options and RSUs excluded from the calculation of diluted weighted average ordinary shares outstanding, because including them would have been antidilutive under the treasury stock method.

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of Sales By Geographic Area

The following table sets forth sales by geographic area:

	Three Months Ended
	March 31, 2023		April 1, 2022
United States of America	$	89,052	$	142,470
Singapore	82,286		103,295
Europe	29,986		24,392
Other	24,546		22,989
Total net sales	$	225,870	$	293,146

XML

Basis of Presentation and Selected Significant Accounting Policies - Additional Information (Details)	3 Months Ended
	Mar. 31, 2023
Basis Of Presentation [Line Items]
Original maturities acquisition period	90 days
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-04-01
Basis Of Presentation [Line Items]
Performance obligation satisfaction period	12 months
Minimum
Basis Of Presentation [Line Items]
Extended product warranty period	1 year
Payment terms, due period	15 days
Maximum
Basis Of Presentation [Line Items]
Extended product warranty period	2 years
Payment terms, due period	60 days

XML

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 196,504	$ 197,726
Work in process	39,733	56,291
Finished goods	54,306	47,186
Excess and obsolete adjustment	(19,005)	(17,543)
Total inventories	$ 271,538	$ 283,660

XML

Property and Equipment and Other Noncurrent Assets - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 173,212	$ 164,907
Less accumulated depreciation	(71,731)	(66,852)
Total property and equipment, net	101,481	98,055
Machinery
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	96,338	90,507
Leasehold improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	43,556	43,129
Computer software, hardware, and equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	10,053	9,664
Office furniture, fixtures, and equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	1,354	1,337
Vehicles
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	401	401
Construction-in-process
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 21,510	$ 19,869

XML

Property and Equipment and Other Noncurrent Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 4.3	$ 4.0

XML

Property and Equipment and Other Noncurrent Assets - Summary of Capitalized Cloud Computing Implementation Cost (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Capitalized cloud computing implementation cost	$ 11.4		$ 11.6
Capitalized costs amortized during the period	$ (0.2)	$ (0.2)

XML

Intangible Assets - Schedule of Definite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2023	Jun. 30, 2022	Dec. 31, 2022
Finite Lived Intangible Assets [Line Items]
Gross value	$ 128,069		$ 128,069
Accumulated amortization	(60,013)		(56,047)
Carrying amount	68,056		72,022
Customer relationships
Finite Lived Intangible Assets [Line Items]
Gross value	117,022		117,022
Accumulated amortization	(55,202)		(51,337)
Carrying amount	$ 61,820		65,685
Customer relationships | Weighted Average
Finite Lived Intangible Assets [Line Items]
Weighted average useful life	8 years 4 months 24 days	8 years 4 months 24 days
Developed technology
Finite Lived Intangible Assets [Line Items]
Gross value	$ 11,047		11,047
Accumulated amortization	(4,811)		(4,710)
Carrying amount	$ 6,236		$ 6,337
Developed technology | Weighted Average
Finite Lived Intangible Assets [Line Items]
Weighted average useful life	10 years	10 years

XML

Leases - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Non-cancellable net operating lease expiration year	2031

XML

Leases - Components of Lease Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating lease cost	$ 2,411	$ 2,045

XML

Leases - Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating cash flows from operating leases	$ 2,237	$ 1,823

XML

Leases - Supplemental Balance Sheet Information Related to Leases (Detail)	Mar. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Weighted-average remaining lease term of operating leases	5 years 2 months 12 days	5 years 3 months 18 days
Weighted-average discount rate of operating leases	3.20%	3.00%

XML

Leases - Future Minimum Lease Payments Under Non-Cancelable Leases (Detail) $ in Thousands	Mar. 31, 2023 USD ($)
Leases [Abstract]
2023, remaining	$ 7,117
2024	9,074
2025	8,418
2026	7,968
2027	6,968
Thereafter	5,367
Total future minimum lease payments	44,912
Less imputed interest	(3,467)
Total lease liabilities	$ 41,445

XML

Income Taxes - Schedule of Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]
Income tax expense (benefit)	$ (535)	$ 810
Income (loss) before income taxes	$ (540)	$ 8,849
Effective income tax rate	99.10%	9.20%

XML

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Effective income tax rate	99.10%	9.20%
Unrecognized tax benefits for uncertain tax positions	$ 4.5

XML

Employee Benefit Programs - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Defined Contribution Plan Disclosure [Line Items]
Percentage of maximum annual contributions per employee	50.00%
Percentage of eligible employee receive discretionary matching contribution	50.00%
Employee matching contributions	$ 0.9	$ 1.0
Maximum
Defined Contribution Plan Disclosure [Line Items]
Percentage of maximum annual contributions per employee	4.00%

XML

Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Line Of Credit Facility [Line Items]
Total principal amount of long-term debt	$ 300,625	$ 302,500
Less unamortized debt issuance costs	(1,666)	(1,782)
Total long-term debt, net	298,959	300,718
Less current portion	(7,500)	(7,500)
Long-term debt, less current portion, net	291,459	293,218
Term loan
Line Of Credit Facility [Line Items]
Total principal amount of long-term debt	140,625	142,500
Revolving credit facility
Line Of Credit Facility [Line Items]
Total principal amount of long-term debt	$ 160,000	$ 160,000

XML

Long-Term Debt - Additional Information (Details) - USD ($) $ in Thousands	Oct. 29, 2021	Mar. 31, 2023	Dec. 31, 2022
Line Of Credit Facility [Line Items]
Principal amount of long-term debt		$ 300,625	$ 302,500
Term loan
Line Of Credit Facility [Line Items]
Principal amount of long-term debt		140,625	142,500
Revolving credit facility
Line Of Credit Facility [Line Items]
Principal amount of long-term debt		$ 160,000	$ 160,000
Credit Agreement | Federal Funds Effective Rate
Line Of Credit Facility [Line Items]
Basis spread on variable rate	0.50%
Credit Agreement | BSBY Rate
Line Of Credit Facility [Line Items]
Basis spread on variable rate	1.00%
Credit Agreement | Maximum | BSBY Rate
Line Of Credit Facility [Line Items]
Additional basis spread on variable rate	2.375%
Credit Agreement | Maximum | Base Rate
Line Of Credit Facility [Line Items]
Additional basis spread on variable rate	1.375%
Credit Agreement | Minimum | BSBY Rate
Line Of Credit Facility [Line Items]
Additional basis spread on variable rate	1.375%
Credit Agreement | Minimum | Base Rate
Line Of Credit Facility [Line Items]
Additional basis spread on variable rate	0.375%
Credit Agreement | Term loan
Line Of Credit Facility [Line Items]
Principal amount of long-term debt	$ 150,000
Credit facility, periodic principal payments	1,900
Credit Agreement | Term loan | BSBY Rate
Line Of Credit Facility [Line Items]
Interest rate		6.51%
Credit Agreement | Revolving credit facility
Line Of Credit Facility [Line Items]
Principal amount of long-term debt	$ 250,000
Credit Agreement | Revolving credit facility | Maximum
Line Of Credit Facility [Line Items]
Percentage of commitment fee on unused portion of revolver	0.35%
Credit Agreement | Revolving credit facility | Minimum
Line Of Credit Facility [Line Items]
Percentage of commitment fee on unused portion of revolver	0.175%

XML

Share-Based Compensation - Additional Information (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense for options, RSUs and employee share purchase rights across all plans	$ 3.6	$ 2.9
The 2016 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, expiration period	4 years
Awards vesting percentage	25.00%
Awards vesting period	3 years
2017 Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Purchase price equal to percentage of fair market value of ordinary shares	85.00%
2017 Employee Stock Purchase Plan | Ordinary Shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Ordinary shares remain available for purchase	2.2

XML

Share-Based Compensation - Schedule of Option Activity (Details) - Service condition $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of stock options, outstanding, beginning balance (in shares) | shares	805,115
Number of stock options, granted (in shares) | shares	0
Number of stock options issued from exercise of stock options (in shares) | shares	92,766
Number of stock options forfeited or expired (in shares) | shares	(1,444)
Number of stock options, outstanding, ending balance (in shares) | shares	710,905
Number of stock options, exercisable (in shares) | shares	634,134
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average exercise price per share, outstanding, beginning balance (in usd per share) | $ / shares	$ 23.35
Weighted average exercise price per share, granted (in usd per share) | $ / shares	0.00
Weighted average exercise price per share, exercised (in usd per share) | $ / shares	22.91
Weighted average exercise price per share, forfeited or expired (in usd per share) | $ / shares	22.18
Weighted average exercise price per share, outstanding, ending balance (in usd per share) | $ / shares	23.41
Weighted average exercise price per share, exercisable (in usd per share) | $ / shares	$ 23.36
Weighted average remaining contractual term, outstanding	2 years 7 months 6 days
Weighted average remaining contractual term, exercisable	2 years 4 months 24 days
Aggregate intrinsic value, outstanding | $	$ 6,634
Aggregate intrinsic value, exercisable | $	$ 5,951

XML

Share-Based Compensation - Schedule of RSU Activity (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average grant date fair value per share, unvested, beginning balance (in usd per share) | $ / shares	$ 30.26
Weighted average grant date fair value per share, granted (in usd per share) | $ / shares	27.04
Weighted average grant date fair value per share, vested (in usd per share) | $ / shares	33.57
Weighted average grant date fair value per share, forfeited (in usd per share) | $ / shares	31.81
Weighted average grant date fair value per share, unvested, ending balance (in usd per share) | $ / shares	$ 29.78
Restricted Stock Units Service Condition
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of restricted share units, unvested, beginning balance (in shares)	860,595
Number of restricted share units, granted (in shares)	69,675
Number of restricted share units, vested (in shares)	(51,938)
Number of restricted share units, forfeited (in shares)	(11,936)
Number of restricted share units, unvested, ending balance (in shares)	866,396
Performance Condition
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of restricted share units, unvested, beginning balance (in shares)	57,562
Number of restricted share units, granted (in shares)	0
Number of restricted share units, unvested, ending balance (in shares)	57,562
Market Condition
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of restricted share units, unvested, beginning balance (in shares)	86,342
Number of restricted share units, granted (in shares)	0
Number of restricted share units, unvested, ending balance (in shares)	86,342

XML

Earnings per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share Basic And Diluted [Line Items]
Net income (loss)	$ (5)	$ 8,039
Basic weighted average ordinary shares outstanding	28,984,878	28,592,629
Diluted weighted average ordinary shares outstanding	28,984,878	29,023,455
Securities excluded from the calculation of diluted weighted average ordinary shares outstanding	1,879,000	267,000
Net income (loss) per share:
Basic (in usd per share)	$ 0.00	$ 0.28
Diluted (in usd per share)	$ 0.00	$ 0.28
ESPP
Earnings Per Share Basic And Diluted [Line Items]
Dilutive effect of shares	0	2,138
Options
Earnings Per Share Basic And Diluted [Line Items]
Dilutive effect of shares	0	292,828
RSUs
Earnings Per Share Basic And Diluted [Line Items]
Dilutive effect of shares	0	135,860

XML

Segment Information - Additional Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) Segment	Dec. 31, 2022 USD ($)
Segment Reporting [Abstract]
Number of operating segment | Segment	1
Foreign long-lived assets, exclusive of deferred tax assets | $	$ 52.5	$ 52.8

XML

Segment Information - Schedule of Sales By Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total net sales	$ 225,870	$ 293,146
United States of America
Segment Reporting Information [Line Items]
Total net sales	89,052	142,470
Singapore
Segment Reporting Information [Line Items]
Total net sales	82,286	103,295
Europe
Segment Reporting Information [Line Items]
Total net sales	29,986	24,392
Other
Segment Reporting Information [Line Items]
Total net sales	$ 24,546	$ 22,989